These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 10816555)

  • 21. A paradoxical locomotor response in serotonin 5-HT(2C) receptor mutant mice.
    Heisler LK; Tecott LH
    J Neurosci; 2000 Apr; 20(8):RC71. PubMed ID: 10751458
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differences in rapid desensitization of 5-hydroxytryptamine2A and 5-hydroxytryptamine2C receptor-mediated phospholipase C activation.
    Berg KA; Stout BD; Maayani S; Clarke WP
    J Pharmacol Exp Ther; 2001 Nov; 299(2):593-602. PubMed ID: 11602671
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The serotonin 5-HT2C receptor is a prominent serotonin receptor in basal ganglia: evidence from functional studies on serotonin-mediated phosphoinositide hydrolysis.
    Wolf WA; Schutz LJ
    J Neurochem; 1997 Oct; 69(4):1449-58. PubMed ID: 9326273
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of vabicaserin (SCA-136), a selective 5-hydroxytryptamine 2C receptor agonist.
    Dunlop J; Watts SW; Barrett JE; Coupet J; Harrison B; Mazandarani H; Nawoschik S; Pangalos MN; Ramamoorthy S; Schechter L; Smith D; Stack G; Zhang J; Zhang G; Rosenzweig-Lipson S
    J Pharmacol Exp Ther; 2011 Jun; 337(3):673-80. PubMed ID: 21402690
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Agonist high and low affinity state ratios predict drug intrinsic activity and a revised ternary complex mechanism at serotonin 5-HT(2A) and 5-HT(2C) receptors.
    Egan C; Grinde E; Dupre A; Roth BL; Hake M; Teitler M; Herrick-Davis K
    Synapse; 2000 Feb; 35(2):144-50. PubMed ID: 10611640
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Activating mutations of the serotonin 5-HT2C receptor.
    Herrick-Davis K; Egan C; Teitler M
    J Neurochem; 1997 Sep; 69(3):1138-44. PubMed ID: 9282936
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A critical protein kinase C phosphorylation site on the 5-HT(1A) receptor controlling coupling to N-type calcium channels.
    Wu X; Kushwaha N; Albert PR; Penington NJ
    J Physiol; 2002 Jan; 538(Pt 1):41-51. PubMed ID: 11773315
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of rat serotonin 5-HT2C receptors as glycoproteins containing N-linked oligosaccharides.
    Backstrom JR; Westphal RS; Canton H; Sanders-Bush E
    Brain Res Mol Brain Res; 1995 Nov; 33(2):311-8. PubMed ID: 8750891
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of ring fluorination on the pharmacology of hallucinogenic tryptamines.
    Blair JB; Kurrasch-Orbaugh D; Marona-Lewicka D; Cumbay MG; Watts VJ; Barker EL; Nichols DE
    J Med Chem; 2000 Nov; 43(24):4701-10. PubMed ID: 11101361
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of serotonin 5-hydroxytryptamine2c receptor function through heterodimerization: receptor dimers bind two molecules of ligand and one G-protein.
    Herrick-Davis K; Grinde E; Harrigan TJ; Mazurkiewicz JE
    J Biol Chem; 2005 Dec; 280(48):40144-51. PubMed ID: 16195233
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New serotonin 5-HT(2A), 5-HT(2B), and 5-HT(2C) receptor antagonists: synthesis, pharmacology, 3D-QSAR, and molecular modeling of (aminoalkyl)benzo and heterocycloalkanones.
    Brea J; Rodrigo J; Carrieri A; Sanz F; Cadavid MI; Enguix MJ; Villazón M; Mengod G; Caro Y; Masaguer CF; Raviña E; Centeno NB; Carotti A; Loza MI
    J Med Chem; 2002 Jan; 45(1):54-71. PubMed ID: 11754579
    [TBL] [Abstract][Full Text] [Related]  

  • 32. S32212, a novel serotonin type 2C receptor inverse agonist/α2-adrenoceptor antagonist and potential antidepressant: I. A mechanistic characterization.
    Millan MJ; Mannoury la Cour C; Chanrion B; Dupuis DS; Di Cara B; Audinot V; Cussac D; Newman-Tancredi A; Kamal M; Boutin JA; Jockers R; Marin P; Bockaert J; Muller O; Dekeyne A; Lavielle G
    J Pharmacol Exp Ther; 2012 Mar; 340(3):750-64. PubMed ID: 22178752
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antagonist binding at 5-HT(2A) and 5-HT(2C) receptors in the rabbit: high correlation with the profile for the human receptors.
    Aloyo VJ; Harvey JA
    Eur J Pharmacol; 2000 Oct; 406(2):163-9. PubMed ID: 11020478
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The 5-hydroxytryptamine(4a) receptor is palmitoylated at two different sites, and acylation is critically involved in regulation of receptor constitutive activity.
    Ponimaskin EG; Heine M; Joubert L; Sebben M; Bickmeyer U; Richter DW; Dumuis A
    J Biol Chem; 2002 Jan; 277(4):2534-46. PubMed ID: 11706023
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serotonin activates murine alveolar macrophages through 5-HT2C receptors.
    Mikulski Z; Zaslona Z; Cakarova L; Hartmann P; Wilhelm J; Tecott LH; Lohmeyer J; Kummer W
    Am J Physiol Lung Cell Mol Physiol; 2010 Aug; 299(2):L272-80. PubMed ID: 20495077
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regional distribution and cellular localization of 5-HT2C receptor mRNA in monkey brain: comparison with [3H]mesulergine binding sites and choline acetyltransferase mRNA.
    López-Giménez JF; Mengod G; Palacios JM; Vilaró MT
    Synapse; 2001 Oct; 42(1):12-26. PubMed ID: 11668587
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neuroendocrine evidence that (S)-2-(chloro-5-fluoro-indol- l-yl)-1-methylethylamine fumarate (Ro 60-0175) is not a selective 5-hydroxytryptamine(2C) receptor agonist.
    Damjanoska KJ; Muma NA; Zhang Y; D'Souza DN; Garcia F; Carrasco GA; Kindel GH; Haskins KA; Shankaran M; Petersen BR; Van De Kar LD
    J Pharmacol Exp Ther; 2003 Mar; 304(3):1209-16. PubMed ID: 12604698
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Altered G protein-coupling functions of RNA editing isoform and splicing variant serotonin2C receptors.
    Wang Q; O'Brien PJ; Chen CX; Cho DS; Murray JM; Nishikura K
    J Neurochem; 2000 Mar; 74(3):1290-300. PubMed ID: 10693963
    [TBL] [Abstract][Full Text] [Related]  

  • 39. WAY-163909 [(7bR, 10aR)-1,2,3,4,8,9,10,10a-octahydro-7bH-cyclopenta-[b][1,4]diazepino[6,7,1hi]indole], a novel 5-hydroxytryptamine 2C receptor-selective agonist with anorectic activity.
    Dunlop J; Sabb AL; Mazandarani H; Zhang J; Kalgaonker S; Shukhina E; Sukoff S; Vogel RL; Stack G; Schechter L; Harrison BL; Rosenzweig-Lipson S
    J Pharmacol Exp Ther; 2005 May; 313(2):862-9. PubMed ID: 15705738
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serotonin(2C) receptors tonically suppress the activity of mesocortical dopaminergic and adrenergic, but not serotonergic, pathways: a combined dialysis and electrophysiological analysis in the rat.
    Gobert A; Rivet JM; Lejeune F; Newman-Tancredi A; Adhumeau-Auclair A; Nicolas JP; Cistarelli L; Melon C; Millan MJ
    Synapse; 2000 Jun; 36(3):205-21. PubMed ID: 10819900
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.